Hunan Er Kang Pharmaceutical (300267) — Cash Flow Reinvestment Rate
Hunan Er Kang Pharmaceutical (300267) has a Cash Flow Reinvestment Rate of 0.46x as of June 2023, reinvesting CN¥80.56 Million (capex CN¥45.68 Million plus investments CN¥34.88 Million) from operating cash flow of CN¥174.55 Million. See 300267 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Er Kang Pharmaceutical Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hunan Er Kang Pharmaceutical across 17 annual periods. For the full cash flow conversion analysis, see Hunan Er Kang Pharmaceutical operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year capital reinvestment analysis for Hunan Er Kang Pharmaceutical. See 300267 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.11x | CN¥517.75 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +34.4% |
| 2023 | 2.31x | CN¥343.11 Million | CN¥148.42 Million | CN¥238.19 Million | ▲ +137.5% |
| 2022 | 0.97x | CN¥273.49 Million | CN¥281.02 Million | CN¥173.49 Million | ▼ -87.2% |
| 2021 | 7.60x | CN¥704.27 Million | CN¥92.68 Million | CN¥349.33 Million | ▲ +27.7% |
| 2020 | 5.95x | CN¥1.06 Billion | CN¥178.53 Million | CN¥605.89 Million | ▲ +431.5% |
| 2019 | 1.12x | CN¥498.88 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -40.1% |
| 2018 | 1.87x | CN¥231.39 Million | CN¥123.89 Million | CN¥96.72 Million | ▲ +269.0% |
| 2017 | 0.51x | CN¥348.81 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -80.8% |
| 2016 | 2.64x | CN¥1.29 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +140.4% |
| 2015 | 1.10x | CN¥570.53 Million | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥527.42 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥203.98 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥231.28 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥43.87 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥65.05 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥19.64 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥12.62 Million | CN¥211.00K | CN¥12.62 Million | — |